Chris Broderick

Chris Broderick is the Chief Executive Officer at Merakris Therapeutics, Inc. since 2016. As the Founder & President, Chris founded the company to develop evidence-based therapeutic technologies, secured financing for operations, and supported market access strategy. Chris also served as President at the company, aiming to improve patient lives with regenerative tools. As a consultant, Chris led regulatory and quality initiatives for a medical device company. With a background in founding and leading various companies in the biomedical industry, Chris has extensive experience in intellectual property development, regulatory affairs, financial management, and commercial operations. Chris is currently pursuing a Master's of Science in Biomanufacturing from North Carolina State University.